Maria Albanese Selected Research

Maria Albanese Research Topics

Disease

11	Migraine Disorders (Migraine) 11/2022 - 05/2020
7	Multiple Sclerosis 10/2021 - 02/2016
6	Headache (Headaches) 02/2022 - 05/2020
5	Relapsing-Remitting Multiple Sclerosis 10/2021 - 01/2017
3	Pain (Aches) 02/2022 - 01/2017
3	Narcolepsy 01/2015 - 08/2014
2	COVID-19 02/2022 - 04/2021
2	Hyperalgesia 10/2021 - 10/2021
2	Disease Progression 01/2020 - 02/2016
2	Inflammation (Inflammations) 01/2020 - 01/2017
2	Parkinson Disease (Parkinson's Disease) 03/2019 - 01/2016
2	Cognitive Dysfunction 12/2014 - 06/2013
2	Dementia (Dementias) 12/2014 - 06/2013
1	Epilepsy (Aura) 02/2022
1	Ganglion Cysts (Ganglion) 10/2021
1	Optic Neuritis (Retrobulbar Neuritis) 10/2021
1	Genetic Predisposition to Disease (Genetic Predisposition) 04/2021
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 04/2021
1	Substance-Related Disorders (Drug Abuse) 04/2021
1	Infections 04/2021
1	Severe Acute Respiratory Syndrome 04/2021
1	Central Serous Chorioretinopathy 01/2021
1	Post-Traumatic Headache 05/2020
1	Traumatic Brain Injuries (Traumatic Brain Injury) 05/2020
1	Sleep Apnea Syndromes (Sleep Apnea) 12/2019
1	Neuroinflammatory Diseases 11/2019
1	Bradycardia 11/2019
1	Disorders of Excessive Somnolence (Hypersomnia) 03/2019
1	Sleepiness 03/2019
1	Immune Reconstitution Inflammatory Syndrome 01/2017
1	Progressive Multifocal Leukoencephalopathy 01/2017
1	Mitochondrial Diseases (Mitochondrial Disease) 02/2016
1	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2016
1	Autosomal Dominant Nocturnal Frontal Lobe Epilepsy 04/2015
1	Frontal Lobe Epilepsy (Epilepsy, Supplementary Motor) 04/2015
1	Cataplexy 01/2015
1	Restless Legs Syndrome (Restless Legs) 01/2015
1	Sleep Deprivation 03/2013

Drug/Important Bio-Agent (IBA)

5	galcanezumabIBA 11/2022 - 12/2020
4	fremanezumabIBA 06/2022 - 02/2022
4	Biomarkers (Surrogate Marker)IBA 02/2022 - 06/2013
3	Tryptamines (Triptans)IBA 01/2022 - 04/2021
3	tau Proteins (tau Protein)IBA 12/2014 - 06/2013
2	erenumabIBA 02/2022 - 10/2021
2	palmidrolIBA 02/2022 - 04/2021
2	AntioxidantsIBA 02/2022 - 11/2019
2	Analgesics (Analgesic Drugs)IBA 10/2021 - 04/2021
2	Pharmaceutical PreparationsIBA 04/2021 - 03/2018
2	Fingolimod Hydrochloride (FTY720)FDA Link 01/2021 - 03/2018
2	LipidsIBA 01/2020 - 11/2016
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 11/2019 - 04/2015
2	rotigotine FDA Link 03/2019 - 01/2016
2	Natalizumab (Tysabri)FDA Link 03/2018 - 01/2017
2	OrexinsIBA 12/2014 - 08/2014
2	Amyloid beta-PeptidesIBA 11/2014 - 08/2014
1	Calcitonin Gene-Related PeptideIBA 02/2022
1	Therapeutic UsesIBA 02/2022
1	eptinezumabIBA 02/2022
1	Monoclonal AntibodiesIBA 02/2022
1	Retinaldehyde (Retinal)IBA 10/2021
1	lipoxin B4IBA 01/2020
1	EicosanoidsIBA 01/2020
1	CytokinesIBA 01/2020
1	lipoxin A4IBA 01/2020
1	Acetylcholine (Acetylcholine Chloride)FDA Link 11/2019
1	Dimethyl FumarateIBA 11/2019
1	Cholinergic Agents (Cholinergics)IBA 11/2019
1	InterferonsIBA 01/2017
1	SteroidsIBA 01/2017
1	nitazoxanide (NTZ)FDA Link 01/2017
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2017
1	EndocannabinoidsIBA 01/2017
1	Interferon-betaIBA 01/2017
1	Cetirizine (Zyrtec)FDA LinkGeneric 01/2017
1	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2016
1	anandamide (arachidonylethanolamide)IBA 11/2016
1	Lactic Acid (Lactate)FDA LinkGeneric 02/2016
1	Carnitine (L-Carnitine)FDA LinkGeneric 01/2015
1	Amyloid (Amyloid Fibrils)IBA 12/2014
1	EnzymesIBA 08/2014
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 08/2014
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 08/2014
1	AntigensIBA 08/2014
1	Amyloidogenic ProteinsIBA 06/2013

Therapy/Procedure

5	Therapeutics 01/2022 - 01/2017
1	Injections 05/2020
1	Defibrillators (Defibrillator) 12/2019
1	Plasmapheresis 01/2017
1	Kidney Transplantation 01/2015
1	Duration of Therapy 11/2014
1	Transcranial Magnetic Stimulation 03/2013